Trial intelligence / Profile preview

Effect of metformin on sputum smear conversion in pulmonary tuberculosis with type 2 diabetes mellitus

TCTR20190128004Phase 3Not yet recruiting

Sponsor
Khon Kaen Hospital
Start
Mar 2019
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of metformin in pulmonary tuberculosis (TB), type 2 diabetes mellitus (T2DM), sponsored by Khon Kaen Hospital. Planned start Mar 2019; status: not yet recruiting.

02

Drugs

metformin
03

Conditions

pulmonary tuberculosis (TB)type 2 diabetes mellitus (T2DM)

Beyond the preview

Go deeper on TCTR20190128004.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20190128004.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call